ReportsWeb- Opportunity Analyzer Cystic Fibrosis Opportunity A

Opportunity Analyzer Cystic Fibrosis Opportunity Analysis and
Forecasts to 2025
ReportsWeb.com published “Cystic Fibrosis Opportunity Analysis Market” from its database.
The report covers the market landscape and its growth prospects over the coming years. The
report also includes a discussion of the key vendors operating in this market.
Cystic fibrosis (CF) is an autosomal recessive disease caused by mutations in the cystic fibrosis
transmembrane conductance regulator (CFTR) gene, which codes for the CFTR protein. As a
multisystem condition, CF patients show great heterogeneity in presenting clinical symptoms.
CF mainly affects the respiratory and gastrointestinal tracts. Three classes of drugs have been
used to for treatment in CF patients: inhaled antibiotics for bacterial and fungal respiratory
infections, mucolytic drugs for mucociliary clearance of the airways, and pancreatic enzyme
replacement therapies (PERTs) for treatment of CF induced exocrine pancreatic insufficiency
(EPI) . During the last five years, a new class of drugs was launched into the market, specifically
treating the underlying cause of CF. These CFTR modulators help restore function of the
insufficient CFTR protein. Publisher projects the global cystic fibrosis marketplace to experience
tremendous growth during the forecast period. This growth will be driven primarily by the
highly anticipated arrival of the CFTR modulator, Vertex Pharmaceuticals' ivacaftor/tezacaftor.
Insmed's inhaled antibiotic Arikace (liposomal amikacin) is also expected to launch during the
forecast period but is not expected to drive CF market growth as much as the CFTR modulator,
since it will be competing with other inhaled antibiotics.
For more information about this report: http://www.reportsweb.com/opportunityanalyzer-
cystic-fibrosis-opportunity-analysis-and-forecasts-to-2025
Scope
- Overview of cystic fibrosis, including epidemiology, etiology, pathophysiology, symptoms,
diagnosis, and treatment guidelines.
- Annualized CF therapeutics market revenue, annual cost of therapy and treatment usage
pattern data from 2015 and forecast for ten years to 2025.
- Key topics covered include strategic competitor assessment, market characterization, unmet
needs, clinical trial mapping and implications for the CF therapeutics market.